ASN: Elderly with chronic kidney disease benefit from SGLT2 inhibitors
New data presented at ASN indicates SGLT2 inhibitors improve survival and cognitive function for elderly patients with chronic kidney disease.
15 trends tracked about this subject — the full history, oldest to newest below.
New data presented at ASN indicates SGLT2 inhibitors improve survival and cognitive function for elderly patients with chronic kidney disease.
9 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
A Canadian study warns that common drug combinations are triggering harmful prescribing cascades in older adults, risking their health and independence.
Recent coverage examines inappropriate prescribing cascades where older adults receive new medications to treat side effects.
Health publications and senior care organizations are highlighting targeted solutions to help older adults improve declining balance and reduce fall risks.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
17 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
2 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
New research suggests that long intervals between meals may be linked to faster chronic disease accumulation in adults over the age of 60.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
8 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Medical experts and news outlets are raising alarms over potential muscle loss and frailty risks associated with GLP-1 weight loss drugs in older populations.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.